Drug and pharmaceutical recalls
17732 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix ST9A (30 MG/2 MG/80 MCG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix ST4/PGE 2/LIDO 2 0.1/0.05/0.05 Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix ST4 (3 mg/1.5 mg/300 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix ST3/PGE 2/LIDO 2 0.06/0.2/0.02 Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix ST2/LIDO2/PGE2 0.2/0.1/0.04, Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix ST2 (30 mg/3 mg/100 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix ST1 (30 mg/1.5 mg/50 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix MEDIUM (15/0.5/5) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix MEDIUM (15 mg/0.5 mg/5 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix AT-6 (60 mg/4 mg/0.3 mg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix AT-1 (8 mg/2 mg/0.2 mg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (6.9/0.575/39.375) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (37.5/2/20) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (37.5/2/20) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (37.5 mg/1.5 mg/50 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/2/20) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/2/20) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/1/22) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/1/22) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/1/20) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/1/20) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/1/10) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/1/10) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/0.5/10) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (30/0.5/10) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (25/2.5/10) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (25/2.5/10) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (22.5/0.83/8.3) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (20/2.5/20) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
- 2015-09-23FDA-DrugThe Compounding Pharmacy of AmericaClass IITri-Mix (20/1/10) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief